Under30CEO on MSN
Times analysis questions billionaire timelines
A new analysis has raised questions about a high-profile billionaire’s habit of setting bold timelines and falling short. The ...
In guidance released Monday, the US Food and Drug Administration (FDA) provides the timelines it will stick to when reviewing responses to complete response letters (CRLs) for drugs and biologics when ...
WASHINGTON, April 9, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today highlighted a legislative proposal contained in the FDA's FY 2027 Congressional Budget Justification.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results